IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Evaluating the role of Homeopathic medicine Testosterone in its various attenuations for its anticancer activity on Breast Cancer cell line MCF-7.

Author: DALJEET KAUR, JAY NILESH SHAH, RAHUL M. SONAVALE
Abstract: The second most prevalent type of cancer which is also the leading cause of women death in India is Breast Cancer. In its treatment several recommendation and measures are considered. Androgen receptors have been found on breast cancer cell lines and testosterone has been used as hormone therapy against breast cancer. Homeopathic medicines are part of complementary and alternative medicines are used for the treatment of cancer. The objective of the study is to investigate and evaluate the anticancer activity of commercially available homeopathic preparations of Testosterone. To test the viability of breast cancer (MCF-7) cell line, 3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay was conducted with negative control, ethanol and various attenuations of homeopathic medicine Testosterone at 24 hours. Ethanol was tested to be safe to the cells up to 3µl thereby coherent to the cells being viable up to 3% of alcohol. Multiple comparisons between tested reagents at different concentrations confirmed the significance of the said results. At concentration of 1:33, 6CH and 200CH potency shows superior activity in comparison to negative control, ethanol, 30CH and 1M potency (p<0.001). These preliminary significant results warrant further in vitro and in vivo studies to evaluate the potential of Testosterone as a medicine to treat breast cancer.
Keyword: Homeopathy, Breast cancer, Testosterone, in vitro, Anticancer activity.
DOI: https://doi.org/10.31838/ijpr/2019.11.03.025
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477